Advertisement

Comparative Responses to Leukotriene D4 in the Sheep and Cat

  • Philip J. Kadowitz
  • Dennis B. Mcnamara
  • Albert L. Hyman
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Summary

Pulmonary vascular responses to leukotriene (LT) D4 were compared in the sheep and cat under conditions of controlled lobar blood flow. Intralobar injections of LTD4 in the sheep caused dose-dependent increases in lobar arterial and small vein pressures without influencing left atrial or systemic arterial pressure. Leukotriene D4 was very potent in increasing pulmonary vascular resistance in the sheep, with activity similar to U-46619, a thromboxane (Tx) A2 mimic. Pulmonary vascular responses to LTD4 in the sheep were similar when the lung was ventilated and when lobar ventilation was arrested and when the lobe was perfused with blood or with dextran. Pulmonary vasoconstrictor responses to LTD4 but not to U-46619 in the sheep were reduced by inhibitors of cyclooxygenase and thromboxane synthesis. In contrast, LTD4 had modest pressor activity in the pulmonary vascular bed of the cat, whereas U-46619 had marked activity in this species. Responses to LTD4 in the cat were not altered by cyclooxygenase inhibitors.

It is concluded that LTD4 has marked pulmonary vasoconstrictor activity in the sheep, increasing pulmonary vascular resistance by constricting intrapulmonary veins and upstream segments. In this species, responses to LTD4 were independent of changes in ventilation or the interaction with formed elements but were dependent on the formation of cyclooxygenase products including TxA2. However, in the cat, LTD2 had very weak pressor activity, and this activity was not dependent on the integrity of the cyclooxygenase system. These studies indicate that there is considerable species difference in responses to LTD4, a major component of the slow reacting substance of anaphylaxis, in the pulmonary vascular bed.

Keywords

Arachidonic Acid Pulmonary Vascular Resistance Systemic Arterial Pressure Left Atrial Pressure Cyclooxygenase Inhibitor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Borgeat, P., and Samuelsson, B., 1979a, Arachidonic acid metabolism in polymorphonuclear leukocytes: Unstable intermediates in formation of dihydroxy acids, Proc. Natl. Acad. Sci. U.S.A. 76:3212–3217.Google Scholar
  2. Borgeat, P., and Samuelsson, B., 1979b, Metabolism of arachidonic acid in polymorphonuclear leukocytes: Structural analysis of novel hydroxylated compounds, J. Biol. Chem. 254:7865–7869.PubMedGoogle Scholar
  3. Borgeat, P., Hamberg, M., and Samuelsson, B., 1976, Transformation of arachidonic acid and homo-7-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipox-ygenases, J. Biol. Chem. 251:7816–7820.PubMedGoogle Scholar
  4. Brocklehurst, W.E., 1960, The release of histamine and formation of a slow-reacting substance during anaphylactic shock, J. Physiol. (Lond.) 151:416–435.Google Scholar
  5. Coleman, R.A., Humphrey, P.P A., Kennedy, I., Levy, G.P., and Lumley, P., 1981, Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations, Br. J. Pharmacol. 73:773–778.PubMedCrossRefGoogle Scholar
  6. Dahlen, S.E., Hedqvist, P., Hammarström, S., and Samuelsson, B., 1980, Leukotrienes are potent constrictors of human bronchi, Nature 288:484–486.PubMedCrossRefGoogle Scholar
  7. Dahlen, S.E., Hansson, G., Hedqvist, P., Bjorck, T., Granstrom, E., and Dahlen, B., 1983, Allergic challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotriene C4, D4 and E4, Proc. Natl. Acad. Sci. U.S.A. 80:1712–1716.PubMedCrossRefGoogle Scholar
  8. Drazen, J.M., Austen, K.F., Lewis, R.A., Clark, D.A., Goto, G., Marfat, A., and Corey, E.J., 1980, Comparative airway and vascular activities of leukotrienes C-1 and D in vivoand in vitro,Proc. Natl. Acad. Sci. U.S.A. 77:4354–358.CrossRefGoogle Scholar
  9. Engineer, D.M., Morris, H.R., Piper, P.J., and Sirois, P., 1978, The release of prostaglandins and thromboxanes from guinea-pig lung by slow-reacting substances of anaphylaxis and its inhibition, Br. J. Pharmacol. 64:211–218.PubMedCrossRefGoogle Scholar
  10. Ford-Hutchinson, A.W., Bray, M.A., Doig, M.V., Shipley, M.E., and Smith, M.J.H., 1980, Leukotriene B: A potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature 286:264–265.PubMedCrossRefGoogle Scholar
  11. Hammarström, S., 1983, Leukotrienes, Annu. Rev. Biochem. 52:355–377.PubMedCrossRefGoogle Scholar
  12. Hand, J.M., Will, J.A., and Buckner, C.K., 1981, Effects of leukotrienes on isolated guinea-pig pulmonary arteries, Eur. J. Pharmacol. 76:439–443.PubMedCrossRefGoogle Scholar
  13. Holroyde, M.D., Altounyan, R.E.C, Cole, M., Dixon, M., and Elliot, E.V., 1981, Bronchocon-striction produced in man by leukotrienes C and D, Lancet 2:17–18.PubMedCrossRefGoogle Scholar
  14. Hyman, A.L., and Kadowitz, P.J., 1975, Effect of alveolar and perfusion hypoxia and hypercapnia on pulmonary vascular resistance in the lamb, Am. J. Physiol. 228:397–403.PubMedGoogle Scholar
  15. Hyman, A.L., and Kadowitz, P.J., 1979, Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat, Circ. Res. 45:404–409.PubMedCrossRefGoogle Scholar
  16. Hyman, A.L., Mathe, A.A., Leslie, C.A., Matthews, C.C, Bennett, J.T., Spannhake, E.W., and Kadowitz, P.J., 1978, Modification of pulmonary vascular responses to arachidonic acid by alterations in physiologic state, J. Pharmacol. Exp. Ther. 207:388–401.PubMedGoogle Scholar
  17. Hyman, A. L., Spannhake, E. W., and Kadowitz, P. J., 1980, Divergent responses to arachidonic acid in the feline pulmonary vascular bed, Am. J. Physiol. 239:H40–H46.PubMedGoogle Scholar
  18. Iacopino, V.J., Fitzpatrick, T.M., Ramwell, P.W., Rose, J.C, and Kot, P.A., 1983, Cardiovascular responses to leukotriene C4 in the rat, J. Pharmacol. Exp. Ther. 227:244–247.PubMedGoogle Scholar
  19. Jones, T.R., Davis, C, and Daniel, E.E., 1982, Pharmacological study of the contractile activity of leukotrienes C4 and D4 on isolated human airway smooth muscle, Can. J. Physiol. Pharmacol. 60:638–643.PubMedCrossRefGoogle Scholar
  20. Kadowitz, P.J., and Hyman, A.L., 1977, Influence of a prostaglandin endoperoxide analogue on the canine pulmonary vascular bed, Circ. Res. 40:282–287.PubMedCrossRefGoogle Scholar
  21. Kadowitz, P.J., and Hyman, A.L., 1980, Comparative effects of thromboxane B2 on the canine and feline pulmonary vascular bed, J. Pharmacol. Exp. Ther. 213:300–305.PubMedGoogle Scholar
  22. Kadowitz, P. J., and Hyman, A. L., 1983, Pulmonary vascular responses to histamine in sheep, Am. J. Physiol. 244:H423–H428.PubMedGoogle Scholar
  23. Kadowitz, P.J., and Hyman, A.L., 1984, Analysis of responses to leukotriene D4 in the pulmonary vascular bed, Circ. Res. 55:707–717.PubMedCrossRefGoogle Scholar
  24. Kadowitz, P.J., Joiner, P.D., and Hyman, A.L., 1974, Influence of prostaglandins E1 and F2α on pulmonary vascular resistance in the sheep, Proc. Soc. Exp. Biol. Med. 145:1258–1261.PubMedGoogle Scholar
  25. Kallaway, C.H., and Trethewie, E.F., 1940, The liberation of slow reacting smooth muscle-stimulating substances in anaphylaxis, Q. J. Exp. Physiol. 30:121–145.Google Scholar
  26. Krell, R.D., Osborn, R., Vickery, L., Falcone, K., O’Donnell, M., Gleason, J., Kinzig, C, and Bryan, D., 1981, Contraction of isolated airway smooth muscle by synthetic leukotrienes C4 and D4, Prostaglandins 22:387–409.PubMedCrossRefGoogle Scholar
  27. Lewis, R.A., Austen, K.F., Drazen, J.M., Clark, D.A., Marfat, A., and Corey, E.J., 1980, Slow reacting substances of anaphylaxis: Identification of leukotrienes C and D from human and rat sources, Proc. Natl. Acad. Sci. U.S.A. 77:3710–3714.PubMedCrossRefGoogle Scholar
  28. Michelassi, F., Landa, L., Hill, R.D., Lowenstein, E., Watkins, W.D., Petkau, A.J., and Zapol, W.M., 1982, Leukotriene D4: A potent coronary artery vasoconstrictor associated with impaired ventricular contraction, Science 217:841–843.PubMedCrossRefGoogle Scholar
  29. Morris, H.R., Taylor, G.W., Piper, P.J., and Tippins, J.R., 1980, Structure of slow-reacting substance of anaphylaxis from guinea-pig lung, Nature 285:104–108.PubMedCrossRefGoogle Scholar
  30. Murphy, R.C, Hammarström, S., and Samuelsson, B., 1979, Leukotriene C: A slow reacting substance from murine mastocytoma cells, Proc. Natl. Acad. Sci. U.S.A. 76:4275–4279.PubMedCrossRefGoogle Scholar
  31. Orning, L., Hammarström, S., and Samuelsson, B., 1980, Leukotriene D: A slow reacting substance from rat basophilic leukemic cells, Proc. Natl. Acad. Sci. U.S.A. 77:2014–2017.PubMedCrossRefGoogle Scholar
  32. Piper, P.J., and Samhoum, M.N., 1981, The mechanism of action of leukotriene C4 and D4 in guinea-pig isolated perfused lung and parenchymal strips of guinea pig, Prostaglandins 21:793–803.PubMedCrossRefGoogle Scholar
  33. She, H.S., McNamara, D.B., Spannhake, E.W., Hyman, A.L., and Kadowitz, P.J., 1981, Metabolism of prostaglandin endoperoxide by microsomes from cat lung, Prostaglandins 21:531–541.PubMedCrossRefGoogle Scholar
  34. Smedegard, G., Hedqvist, P., Dahlen, S.E., Revenas, B., Hammarström, S., and Samuelsson, B., 1982, Leukotriene C4 affects pulmonary and cardiovascular dynamics in monkey, Nature 295:327–329.PubMedCrossRefGoogle Scholar
  35. Snedecor, C. W., and Cochran, W. G., 1967, Statistical Methods, 6th ed., Iowa State University Press, Ames, IA.Google Scholar
  36. Spannhake, E.W., Hyman, A.L., and Kadowitz, P.J., 1980, Dependency of the airway and pulmonary vascular effects of arachidonic acid upon route and rate of administration, J. Pharmacol. Exp. Ther. 212:584–590.PubMedGoogle Scholar
  37. Spannhake, E.W., Colombo, J.L., Craigo, P.A., McNamara, D.B., Hyman, A.L., and Kadowitz, P.J., 1983, Evidence for modification of pulmonary cyclooxygenase activity by endotoxin in the dog, J. Appl. Physiol. 54:191–198.PubMedGoogle Scholar
  38. Weichman, B.M., Muccitelli, R.M., Osborn, R.R., Holden, D.A., Gleason, J.G., and Wasserman, M.A., 1982, In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig, J. Pharmacol. Exp. Ther. 222:202–208.PubMedGoogle Scholar
  39. Yokochi, K., Olley, P. M., Sideris, E., Hamilton, F., Huhtanen, D., and Coceani, F., 1982, Leukotriene D4: A potent vasoconstrictor of the pulmonary and systemic circulations in the newborn lamb, in: Leukotrienes and Other Lipoxygenase Products (B. Samuelsson and R. Paoletti, eds.), Raven Press, New York, pp. 211–214.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Philip J. Kadowitz
    • 1
  • Dennis B. Mcnamara
    • 1
  • Albert L. Hyman
    • 2
  1. 1.Department of PharmacologyTulane University School of MedicineNew OrleansUSA
  2. 2.Departments of Pharmacology, Surgery, and MedicineTulane University School of MedicineNew OrleansUSA

Personalised recommendations